European Union health regulator approves use of Pfizer’s Covid-19 pill for high-risk groups
Image Credit: shortpdia
The European Medicines Agency (EMA) has conditionally approved the use of US multinational biotechnology firm Pfizer`s Covid-19 pill for treating adults at risk of severe illness. The endorsement allows the member states of the European Union (EU) to deploy the drug after the EMA gave guidance for its emergency use late last year, Xinhua news agency reported.